Latest Breaking News On - Michaela klufas - Page 3 : comparemela.com

/PRNewswire/ Data for Cohort 1 with six months of follow-up from the Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy to be.

United statesRahuln khuranaDana cormackMichaela klufasChris brinzeyTechnology platformTechnology platform licenseesRetina researchThomas jefferson universityNorthern california retina vitreous associatesCorporate communicationsUniversity of california at san franciscoWills eye hospitalMid atlanticClinical associate professorSan francisco